Influenza is the recent attention of the more popular track, but most of the shareholders friends do not understand the concept of influenza stocks which, today financial Jun for the shareholders friends combed out the real influenza concept plate leading stocks list for your reference.
Keren Pharmaceuticals (002422)
Sichuan Keren Pharmaceuticals (002422) Co., Ltd. is mainly engaged in large-volume injections (infusion), small-volume injections (aqueous injections), injectable aseptic powder needles (including dispensed powder needles and lyophilized powder needles), tablets, capsules, granules, oral liquids, peritoneal dialysis solution The company develops, produces and sells 25 dosage forms of pharmaceuticals, antibiotic intermediates, APIs and medical packages. The main products cover anesthesia and analgesia, central nervous system, anti-infection, parenteral nutrition and other fields. In the past three years, 41 generic drugs have been successively approved and listed, 16 varieties have passed consistency evaluation, 2 varieties of innovative drugs have carried out clinical studies in China and the United States, a new generation of tumor immunity drug A293 has been approved for clinical use, and A167, the first innovative drug, has completed the key phase II clinical efficacy assessment. As a representative enterprise of domestic pharmaceutical innovation and high-quality development, the company has won the honors of "Top 20 R&D Enterprises of China Pharmaceutical Group" and "Best Industrial Enterprise of China Pharmaceutical (600056) R&D Product Line 2019"....
Zhongmu (600195)(600195)
Zhongmu Industrial Co. Ltd. is mainly engaged in the research and development, production, sales and technical service of animal health care products and animal nutrition products. The company's main business includes four business segments: biological products, veterinary chemicals, feed and feed additives, and trade. The main products are animal vaccines, poultry vaccines, veterinary chemicals, feed and feed additives. The company has the qualifications of state-recognized enterprise technology center, Beijing Engineering Technology Research Center, Key Laboratory of Veterinary Biological Products and Chemicals of the Ministry of Agriculture, Postdoctoral Workstation and CNAS. The company has once again been awarded the title of "2019 National Product and Service Quality Integrity Unit", and its veterinary vaccines, feed and chemical products have been awarded the title of "2019 National Stable and Qualified Products for Quality Inspection".
*ST Hejia (300273)
Zhuhai Hejia Medical Equipment Co., Ltd. is based on the research and development, manufacturing and sales of medical equipment and consumables, and plans, designs and implements medical professional projects for public hospitals at all levels to build oncology centers, rehabilitation centers, intervention centers and other key clinical disciplines. The company mainly operates minimally invasive tumor treatment equipment, medical molecular sieve oxygen equipment and engineering, conventional diagnostic and therapeutic equipment and medical equipment agent distribution of four business segments. The company has been recognized as a national high-tech enterprises, national intellectual property advantageous enterprises, and approved by the National Bo Management Office set up by the Zhuhai (National) Hengqin New District postdoctoral research station.
New Industry (300832)
Shenzhen New Industry Biomedical Engineering Co., Ltd. is a leader in the field of in vitro diagnostic product development, production, sales and service. The company's products are mainly used to provide diagnostic information for disease prevention, diagnosis, treatment monitoring, prognosis observation, health status evaluation and hereditary disease prediction. NIB is the first company in China to adopt the most advanced "nano-immunomagnetic beads" as the key separation material of the system, the first company in China to adopt the most advanced "synthetic small-molecule organic compounds" as the luminescent markers instead of traditional enzymes, and the first company in China to adopt the most advanced "synthetic small-molecule organic compounds" as the luminescent markers in the field. The first company in China to adopt the most advanced "synthetic small molecule organic compounds" in the field instead of traditional enzymes as luminescent markers, and the first company in China to apply direct chemiluminescence immunoassay technology and realize the mass production of fully automated chemiluminescence immunoassay instruments and supporting reagents.
Nortel Bio(688076)
Jiangsu Nortel Ausano Bio-pharmaceutical Co., Ltd. is a biopharmaceutical company focusing on peptide drugs and small molecule drugs, combining independent research and development and customized research and development production. Our main products are Atorvastatin Calcium Tablets, Amlodipine Atorvastatin Calcium Tablets, APC137 Series, APC037, APC046, APC200, APC214, Alogliptin Benzoate, Etiparatide, Octreotide Acetate, Oseltamivir Phosphate, GLP-1/GIP/GCG Receptor Multi-target Agonist Glucose Lowering Weight Loss Drugs, Fulvestrant.
Fosun Pharma (600196)
Shanghai Fosun Pharma (600196) (Group) Co., Ltd.'s main business is pharmaceuticals, medical devices and medical diagnostics, and healthcare services. The main products are core products in the field of treatment of cardiovascular system diseases, core products in the field of treatment of central nervous system diseases, core products in the field of treatment of blood system diseases, core products in the field of treatment of metabolic and digestive system diseases, core products in the field of treatment of anti-infective diseases, core products in the field of treatment of antitumor, core products in the field of APIs and intermediates. According to the 2018 list of the top 100 enterprises in China's pharmaceutical industry issued by the China Pharmaceutical Industry Information Center of the Ministry of Industry and Information Technology of the People's Republic of China*** and the State of China, the Group was ranked No. 7; according to the IQVIA statistics, in 2019, the Group ranked No. 10 in the country in terms of sales revenue from the hospital-use prescription drugs manufactured by the Group.As one of the largest enterprises in the world in the production, research and development, and manufacturing of anti-malarial medicines, the Group has become a global fund, United Nations Children's Fund, the World Health Organization and the drug procurement centers of African countries...
ST Kangmei (600518)
Kangmei Pharmaceutical Co., Ltd. is principally engaged in the production and sale of Chinese medicine tablets, chemical drugs, etc., as well as the sale of outsourced products and trade in Chinese herbal medicines. The company's main products include Chinese medicine tablets, Chinese medicine formula granules, proprietary Chinese medicines, western medicines, food and health food. The Company is currently one of the enterprises with a more complete business chain, richer medical and healthcare resources and stronger integration capability in the domestic Chinese medicine industry. The Company mainly produces and operates products such as Chinese medicine tablets, western medicines, health food and foodstuffs, proprietary Chinese medicines and medical devices. At present, the company's Chinese medicine tablets business is in a leading position in the industry.
Tongrentang (600085)(600085)
Beijing Tongrentang Co., Ltd.'s main business is the research and development, production, and sales of traditional Chinese medicines; the company's main products are AnGongNiuHuang Pills, Tongren NiuHuangQingXinPian Pills, and Tongren DaxueLuo Pills; Tongrentang is a long-established and prestigious Chinese old Chinese brand in the traditional Chinese medicine industry; Tongrentang is known for Angong Niuhuang Pills, Tongren Niuhuang Qingxin Pills, Tongren Daxuoluo Pills as the representative of the top ten trump card products and many classic medicines household name, famous at home and abroad, in the clinical treatment of patients enjoy a good reputation, the company's business covers 20 countries and regions, the retail terminals up to 71, the formation of the "based in Hong Kong, China, plowing into the mainstream, for the world The company's business covers 20 countries and regions, with retail terminals reaching 71, forming an international network layout "based in Hong Kong, y cultivating the mainstream and facing the world". The trademark "Tongrentang" used by the company belongs to the controlling shareholder, Tongrentang Group, which was recognized as a well-known trademark by the Trademark Bureau of the State Administration for Industry and Commerce in 1989.
Tianjin TEDA (000652)
Tianjin TEDA (000652) Co., Ltd. is mainly engaged in the business of recycling resources such as incineration of domestic garbage to generate electricity and sanitary landfill, food, sludge treatment and biomass power generation. The company's main products and services are chemical and metal products trading, commercial housing, Guangling New City Project, waste treatment and power generation, textile and filter materials. The company has been awarded the second prize of National Scientific and Technological Progress, the first prize of Tianjin Science and Technology Progress Award twice, the National Patent Excellence Award and Tianjin Patent Gold Award, and is the main compiler of several national standards and group standards, which is among the top in the national meltblown nonwoven fabrics industry.
Northeast Pharmaceutical (000597)(000597)
Northeast Pharmaceutical Group Co., Ltd. main business covers chemical pharmaceutical (APIs, preparations), pharmaceutical business (wholesale, chain), pharmaceutical engineering (pharmaceutical design, manufacturing and installation), biopharmaceuticals (bio-diagnostic reagents) and other sectors, forming a Pharmaceutical upstream and downstream industries and service clusters. The company has ten series of high-quality products and more than 400 kinds of chemical raw materials, pharmaceutical intermediates and preparations, such as vitamins, anti-infective products, reproductive system and sex hormones, neurological products, anti-AIDS products, gastrointestinal products, hemp extracts and hemp-containing series of products, other general pharmaceutical products, in-vitro (biological) diagnostic reagents, and products for the field of health, etc., and its leading products are exported to more than 100 countries and regions. The leading products are exported to more than 100 countries and regions.